Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Monti

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
The Journal of Biological Chemistry|July 28, 2004
Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicityDaria Maria Monti, Giuseppe D'Alessio
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin AdductDaria Maria Monti, Domenico Loreto, Ilaria Iacobucci, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 28, 2019
Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studiesDara Maria Monti, Giarita Ferraro, Antonello Merlino
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|April 7, 2018
Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-IRita Del Giudice, Alessandra Pesce, Flora Cozzolino, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 10, 2017
Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levelsRita Del Giudice, Joan Domingo-Espín, Ilaria Iacobucci, et al.
FEBS Letters|October 30, 2016
Apolipoprotein A-I: the dual face of a proteinAngela Arciello, Renata Piccoli, Daria Maria Monti
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 3, 2012
Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acidsDaria Maria Monti, Sonia Di Gaetano, Rita Del Giudice, et al.
European Biophysics Journal : EBJ|February 26, 2010
Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formationDaria Maria Monti, Fulvio Guglielmi, Maria Monti, et al.
Biochimica Et Biophysica Acta|October 31, 2015
Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variantsRita Del Giudice, Angela Arciello, Francesco Itri, et al.
Advances in Experimental Medicine and Biology|July 4, 2026
Methods for the Investigation of Protein-Ligands InteractionsIlaria Iacobucci, Flora Cozzolino, Irene Cipollone, et al.
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
The Journal of Biological Chemistry|July 28, 2004
Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicityDaria Maria Monti, Giuseppe D'Alessio
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin AdductDaria Maria Monti, Domenico Loreto, Ilaria Iacobucci, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 28, 2019
Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studiesDara Maria Monti, Giarita Ferraro, Antonello Merlino
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|April 7, 2018
Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-IRita Del Giudice, Alessandra Pesce, Flora Cozzolino, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 10, 2017
Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levelsRita Del Giudice, Joan Domingo-Espín, Ilaria Iacobucci, et al.
FEBS Letters|October 30, 2016
Apolipoprotein A-I: the dual face of a proteinAngela Arciello, Renata Piccoli, Daria Maria Monti
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 3, 2012
Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acidsDaria Maria Monti, Sonia Di Gaetano, Rita Del Giudice, et al.
European Biophysics Journal : EBJ|February 26, 2010
Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formationDaria Maria Monti, Fulvio Guglielmi, Maria Monti, et al.
Biochimica Et Biophysica Acta|October 31, 2015
Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variantsRita Del Giudice, Angela Arciello, Francesco Itri, et al.
Advances in Experimental Medicine and Biology|July 4, 2026
Methods for the Investigation of Protein-Ligands InteractionsIlaria Iacobucci, Flora Cozzolino, Irene Cipollone, et al.
Pageof 28